Received Nov 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLUN3 | INFLUENZA (SEASONAL) (FLUMIST) | MEDIMMUNE VACCINES, INC. | UNK | — | OT |
WHEEZING; FEVER; COUGH; A spontaneous report has been received from a consumer. The report concerns a male child patient of [withheld] ethnic origin born in 2019 (age 5 years, height 119 cm, weight 24.04 kg). No medical history was reported. No concomitant products were reported. The patient received Flumist, via respiratory for flu vaccine on 19-SEP-2025. The patient received 1 dose(s). No malfunction has been reported for the Accuspray Single Dose device. On 20-SEP-25, the patient experienced fever (preferred term: Pyrexia) and cough (preferred term: Cough). On 21-SEP-25, the patient experienced wheezing (preferred term: Wheezing). The outcome of the event(s) of cough and wheezing was unknown. At the time of reporting, the event fever was improving. The events were considered non-serious. Device Information: Combination Product Report: Yes Product As Reported: Flumist Brand Name: FLUMIST Product Role:Suspect Device Problem code:Adverse Event Without Identified Device or Use Problem Manufacturer Name:ASTRAZENECA Labeled for single use:No Non-Significant correction 15-Oct-25: Null favors for county data field was added. Non-Significant correction on 04-Nov-2025: Null flavor from the vaccine facility state removed. Narrative amended. Non-significant correction 05-NOV-2025: Null flavor removed for telephone and fax , Narrative amended
Flu
Comments: N/a. Never had any reactions to vaccines previously.